TWTerri L. Warholak

Terri L. Warholak

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Terri L. Warholak has a total of 106 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Reliability and Validity Evidence for an Academic Gender Equity Questionnaire

    by Terri Warholak, Jamie C. Barner, Elizabeth Unni, Tyan F. Thomas, Radhika Devraj, Ana C. Quiñones-Boex, Michelle L. Blakely, Michelle A. Clark, Adriane N. Irwin, Karen Nagel-Edwards, et al.

    Objective: The majority of practicing pharmacists and student pharmacists are women. However, instruments to assess perceptions of gender equity within pharmacy academia are not available. The objective of this manuscript is to describe the psychometric analysis of a questionnaire developed to assess gender equity by a Gender Equity Task Force and to report reliability and validity evidence. Methods: A questionnaire was created, including 21 five-point scale questions addressing: teaching; research; service; advancement; mentoring; recruitment; and gender of college leaders. The survey was distributed via email in December 2020 to all social and administrative science section members of two professional associations. Rasch analysis was performed to evaluate the reliability and validity evidence for the questionnaire. Results: After reverse coding, all items met parameters for unidimensionality necessary for Rasch analysis. Once adjacent categories were merged to create a 3-point scale, the scale and items met parameters for appropriate functionality. Items were ordered hierarchically in order of difficulty. The modified instrument and scale can be treated as interval level data for future use. Conclusion: This analysis shows that there is reliability and validity evidence for the gender equity questionnaire for use in the social and administrative academic pharmacy population if recommended edits such as the 3-point scale are used. Future research on gender equity can benefit from use of a psychometrically sound questionnaire for data collection.


  • Open Access

    Evaluation of a Pharmacist-Led Telephonic Medication Therapy Management Program in Rural Arizona: Implications for Community Health Practice

    by David R. Axon, Jim Kloster, Becka Eckert, Sonia Morales, Sally Riggs, Aminata Kilungo, John Ehiri, Megan Grieser, Tenneh Turner-Warren, Teresa Aseret-Manygoats, et al.

    This study evaluated a pharmacist-led telephonic Medication Therapy Management (MTM) program for rural patients in Arizona with poor access to healthcare services. A pharmacist provided telephonic MTM services to eligible adult patients living in rural Arizona communities with a diagnosis of diabetes and/or hypertension. Data were collected and summarized descriptively for demographic and health conditions, clinical values, and medication-related problems (MRPs) at the initial consultation, and follow-up data collected at 1 and 3 months. A total of 33 patients had baseline and one-month follow-up data, while 15 patients also had three-month follow-up data. At the initial consultation, the following MRPs were identified: medication adherence issues, dose-related concerns, adverse drug events (ADE), high-risk medications, and therapeutic duplications. Recommendations were made for patients to have the influenza, herpes zoster, and pneumonia vaccines; and to initiate a statin, angiotensin converting enzyme inhibitor, angiotensin receptor blocker, beta-blocker, and/or rescue inhaler. In conclusion, this study demonstrated that while pharmacists can identify and make clinical recommendations to patients, the value of these interventions is not fully realized due to recommendations not being implemented and difficulties with patient follow-up, which may have been due to the COVID-19 pandemic. Additional efforts to address these shortcomings are therefore required.


  • Open Access

    Program of All-Inclusive Care for the Elderly (PACE) versus Other Programs: A Scoping Review of Health Outcomes

    by Daniel Arku, Mariana Felix, Terri Warholak, David R. Axon

    The Program of All-Inclusive Care for the Elderly (PACE) provides comprehensive health and social services to community-dwelling older United States (US) adults. However, little is known about how PACE outcomes compare to similar caregiving programs. This scoping review searched nine databases to identify studies that compared economic, clinical, or humanistic outcomes of PACE to other caregiving programs in the US. Two reviewers independently screened and extracted data from relevant articles and resolved discrepancies through consensus. From the 724 articles identified, six studies were included. Example study outcomes included: limitations and needs, survival and mortality, healthcare utilization, and economic outcomes. In conclusion, there are few published comparisons of PACE outcomes versus other caregiving programs for older US adults, and identified studies indicate mixed results. Further studies are needed to compare PACE outcomes to other programs so that policymakers are well informed to manage and optimize health outcomes for the growing US older adult population.


  • Open Access

    Exploring the Association of the COVID-19 Pandemic on Employee Sleep Quality at a Healthcare Technology and Services Organization

    by Daniel Arku, Jennifer M. Bingham, Jacques Turgeon, Veronique Michaud, Terri Warholak, David R. Axon

    The COVID-19 pandemic led to global healthcare consequences including insomnia. This survey used the Pittsburgh Sleep Quality Index (PSQI) to assess sleep quality at two time points (July 2020 and November 2020) among employees at a healthcare technology and services organization during the COVID-19 pandemic. Of the 1280 eligible employees, 251 complete responses (response rate, RR = 19.6%) in July and 108 (RR = 8.4%) in November were received and analyzed. The overall mean global PSQI scores were 7.3 ± 3.6 in July and 7.7 ± 3.6 in November 2020 (p > 0.05). There was no significant difference in any of the PSQI components or global scores between periods. Our findings indicate poor reported sleep quality among our study participants during the COVID-19 pandemic. Additional studies are needed to assess the longitudinal impact on sleep quality post-COVID-19 pandemic.

  • Open Access

    Validation Assessment of a Pain Interference Questionnaire among Student Pharmacists

    by Megan Whaley, Nouf Bin Awad, Terri Warholak, David Rhys Axon

    Validation studies of pain interference instruments used among student pharmacists are rare yet essential for understanding their appropriate use and interpretation in pharmacy education and practice. This study conducted validation and reliability assessments of a five-item Pain Interference Scale previously administered to student pharmacists. Construct validity was assessed using Rasch analysis. Unidimensionality was measured using: point-biserial measure correlations; percent of raw variance explained by items; difference between expected; variance modeled by items; and Rasch model fit. To assess scale functioning, response frequency distribution, observed average and sample expected logit distribution, Andrich logit distribution, item separation, and item reliability were assessed. Visual examination of the Item-Person Map determined content validity. Items explained 64.2% of data raw variance. The difference between raw variance modeled and observed was 0.6. Point-biserial measure correlations were >0.77. Item mean-square infits were 0.7–1.3 while outfit measures were 0.72–1.16. There were >10 responses per response category, response frequency and Andrich thresholds progressively advanced, and observed average and sample expected logits advanced monotonically, Andrich logits = −2.33–1.69, item separation = 2.61, and item reliability = 0.87. Item probability curves indicated response categories were minimally yet adequately distinct. Cronbach’s alpha = 0.93. The Item-Person Map had a ceiling effect indicating content gaps. In conclusion, the pain interference instrument has acceptable construct validity yet contains content gaps. Additional difficult items should be added to the instrument to better capture pain interference among student pharmacists.


  • Validation of a pre-/post-survey to measure change in student social justice attitudes and empathy

    by Shannon Vaffis, Elizabeth J. Anderson, Rebekah M. Fettkeather, Terri Warholak, Elizabeth Hall-Lipsy


  • Open Access

    Evaluation of a Novel Pharmacist-Delivered Adherence Improvement Service via Telehealth

    by Srujitha Marupuru, Harman Dhatt, Jennifer M. Bingham, Terri Warholak

    Nearly half of all patients prescribed a chronic medication do not adhere to their regimen. Conversion from a 30- to 90-day medication refill is associated with improved adherence. The objective of the study was to assess the change in proportion of days covered (PDC) in those who converted to a 90-day fill and those who did not after a telehealth pharmacist-delivered, medication adherence intervention. This retrospective review involved data collected between May and December 2018. Patients with ≤85% baseline PDC rates were targeted. One group included patients who converted to a 90-day fill after the pharmacist intervention. The comparator group did not convert to a 90-day fill. Differences in median end-of-year (EOY) PDC rates for each medication class were compared between groups. An alpha level of 0.05 was set a priori. Overall, 237 patients converted to a 90-day fill and 501 did not. There was no significant difference in age, sex, and total number of drugs per patient. A Mann–Whitney U test revealed statistically significant improvements in median EOY PDC in the group that converted to a 90-day fill (+9% vs. −3%, p < 0.001). Pharmacist-delivered telehealth interventions were associated with improved PDC rates in those who converted to a 90-day fill.


  • Open Access

    Assessment of Glycosylated Hemoglobin Outcomes Following an Enhanced Medication Therapy Management Service via Telehealth

    by Jennifer M. Bingham, Jennifer Stanislaw, Terri Warholak, Nicole Scovis, David R. Axon, Jacques Turgeon, Srujitha Marupuru

    (1) Background: Regular contact with a medication therapy management (MTM) pharmacist is shown to improve patients’ understanding of their condition; however, continued demonstration of the value of a pharmacist delivered comprehensive medication review (CMR) using enhanced MTM services via telehealth is needed. The study aimed to describe a pilot program designed to improve type 2 diabetes mellitus (T2DM) management through enhanced condition specific MTM services. (2) Methods: This retrospective study included patients with T2DM aged 40–75 years who received a pharmacist-delivered CMR between January and December 2018. An evaluation of glycosylated hemoglobin (HbA1c) values 3 months pre- and post-CMR was performed. Wilcoxon signed-rank and chi-square tests were used. (3) Results: Of 444 eligible patients, a majority were female (58%) with a median age of 70 years. Median HbA1c values post-CMR were lower than pre-CMR (median 7.1% range 4.5–13.6; median 7.4% range 4.5–13.9, respectively; p = 0.009). There were fewer participants with HbA1c >9% post-CMR (n = 66) than pre-CMR (n = 80; p < 0.001) and more with HbA1C n = 151) than pre-CMR (n = 130; p < 0.001). (4) Conclusion: This program evaluation highlighted the value of an enhanced condition specific MTM service via telehealth. Patients had improved HbA1c values three months after receiving a single pharmacist delivered CMR.


  • Pilot study of focus groups exploring student pharmacists' perceptions of a medication management center internship

    by David R. Axon, Raniah Aljadeed, Pemmarin Potisarach, Stephanie Forbes, Jessica DiLeo, Terri Warholak